Lanthanum carbonate
- Generic Name
- Lanthanum carbonate
- Brand Names
- Fosrenol
- Drug Type
- Small Molecule
- Chemical Formula
- C3La2O9
- CAS Number
- 587-26-8
- Unique Ingredient Identifier
- 0M78EU4V9H
- Background
Lanthanum carbonate is a phosphate binder commonly used in clinical practice. It is marketed under the trade name Fosrenol by Shire Pharmaceuticals. It is the largest of all pills filled in community pharmacies. Sometimes patients forget that Fosrenol is not swallowed whole, but instead should be chewed. This has led to severe choking. It is prescribed for t...
- Indication
Used to reduce serum phosphate in patients with end stage renal disease (ESRD).
- Associated Conditions
- Hyperphosphataemia
- Associated Therapies
- -
Different Effects of Non-calcium Phosphate Binders on Serum Calcium
- Conditions
- Interventions
- First Posted Date
- 2018-03-01
- Last Posted Date
- 2021-07-27
- Lead Sponsor
- Medical University of Lodz
- Target Recruit Count
- 34
- Registration Number
- NCT03451019
- Locations
- 🇵🇱
Department of Nephrology, Hypertension and Kidney Transplantation, Łódź, Poland
Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2021-01-08
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 35
- Registration Number
- NCT03346369
- Locations
- 🇧🇪
University Hospital Brussels, Brussels, Belgium
Healthy Combine Study
- Conditions
- Interventions
- First Posted Date
- 2017-05-02
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 39
- Registration Number
- NCT03136705
- Locations
- 🇺🇸
Center for Translational Metabolism and Health (CTMH), Northwestern University, Chicago, Illinois, United States
The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE
- Conditions
- Interventions
- First Posted Date
- 2014-10-07
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 205
- Registration Number
- NCT02258074
- Locations
- 🇺🇸
NorthShore University Health System, Chicago, Illinois, United States
🇺🇸Denver Nephrology Research, Denver, Colorado, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
- Conditions
- Interventions
- First Posted Date
- 2014-09-11
- Last Posted Date
- 2021-02-25
- Lead Sponsor
- Osaka University
- Target Recruit Count
- 60
- Registration Number
- NCT02237534
- Locations
- 🇯🇵
Osaka University Hospital, Suita, Osaka, Japan
Phosphate Lowering in CKD Trial
- First Posted Date
- 2014-08-06
- Last Posted Date
- 2022-08-26
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 66
- Registration Number
- NCT02209636
- Locations
- 🇺🇸
Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora, Colorado, United States
The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23
- Conditions
- Interventions
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2013-05-03
- Lead Sponsor
- Camillians Saint Mary's Hospital Luodong
- Target Recruit Count
- 30
- Registration Number
- NCT01845090
- Locations
- 🇨🇳
Saint Mary's hospital-Lotung, Taipei, Taiwan
A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis
- Conditions
- Interventions
- First Posted Date
- 2012-10-01
- Last Posted Date
- 2021-06-10
- Lead Sponsor
- Shire
- Target Recruit Count
- 63
- Registration Number
- NCT01696279
- Locations
- 🇭🇺
Szegedi Tudomanyegyetem Altalanos Orvostudomanyi Kar, Szeged, Hungary
🇨🇿Fakultni nemocnice Ostrava, Ostrava, Czechia
🇩🇪Medizinische Hochschule Hannover, Hannover, Germany
Fosrenol and Phosphorus Balance - Lanthanum Carbonate
- Conditions
- Interventions
- First Posted Date
- 2012-04-20
- Last Posted Date
- 2017-05-09
- Target Recruit Count
- 9
- Registration Number
- NCT01581996
- Locations
- 🇺🇸
Harbor-UCLA Medical Center, Torrance, California, United States
Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study
- Conditions
- Interventions
- First Posted Date
- 2012-04-16
- Last Posted Date
- 2020-11-30
- Target Recruit Count
- 2309
- Registration Number
- NCT01578200
- Locations
- 🇯🇵
Showa University, Shinagawa, Tokyo, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.